INNOVATE Corp.
corporate_fare Company Profile
INNOVATE Corp. (NYSE:VATE) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 23 items for VATE at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- INNOVATE's Q4 Revenue Soars 61.7%, Net Loss Significantly Narrows
- INNOVATE's MediBeacon Subsidiary Receives Top Medical Journal Recognition for Kidney Function System
- INNOVATE Corp. to Receive $4.6 Million Cash Dividend from Subsidiary DBM Global
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$1.25B
Net Income
-$60.6M
Diluted EPS
-$4.84
Op. Cash Flow
$146.6M
Free Cash Flow
$146.1M
Gross Profit
$199.7M
Operating Income
$28.7M
Cash & Equivalents
$112.1M
Total Debt
$581.4M
Debt / Equity
-2.42×
Net Margin
-4.9%
Shares Outstanding
13.66M sh
Source: 10-K · filed 2026-03-26 · accession 0001006837-26-000014
show_chartPrice Chart
Loading chart...
feed VATE - Filings & News (Page 2)
VATE
Mar 26, 2026, 4:17 PM EDT
Price at Filing:
$4.03
Real-time Price:
$7.16
Change:
+$3.13 (+78%)
Market Cap:
$97.676M
VATE
Feb 10, 2026, 4:08 PM EST
INNOVATE's MediBeacon Subsidiary Receives Top Medical Journal Recognition for Kidney Function System
Price at Filing:
$5.42
Real-time Price:
$7.16
Change:
+$1.74 (+32%)
Market Cap:
$97.676M
VATE
Feb 02, 2026, 8:32 AM EST
Price at Filing:
$5.63
Real-time Price:
$7.16
Change:
+$1.53 (+27%)
Market Cap:
$97.676M